/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR

Chronicles

The story behind the story

days · browse · Enter similar · o open

Sources: Apple has delayed adding a blood pressure monitor to Watch until 2024, possibly 2025, after difficulties with accuracy during testing

Apple Inc.'s plan to add a highly anticipated blood-pressure monitor to its smartwatch has hit some snags and the technology isn't expected …

Bloomberg Mark Gurman

Context & Ripple Effects

Apple had previously targeted blood-pressure monitoring among Watch health additions as soon as 2022. The accuracy problems reported here turn that earlier health-feature timetable into a longer engineering and validation effort.

The delay matters because later Watch planning still centers health capabilities, including an elevated blood-pressure sensor planned for 2024. Apple is therefore preserving the feature direction while moving its availability behind the rest of the product roadmap.

First-order effects

  • Apple must keep the blood-pressure monitor out of the near-term Watch release cycle while it addresses the testing accuracy issues.
  • Watch buyers expecting the previously signaled health capability face a later rollout, rather than its arrival alongside the earlier set of planned health features.

Second-order effects

  • Apple's 2024 Watch health roadmap has less room to treat blood-pressure monitoring as a completed feature, making accuracy resolution a gating item for the sensor's launch.
  • The distinction between a full monitor and the later-planned elevated-pressure sensor becomes material: Apple can advance adjacent health features without claiming the delayed capability is ready.

Third-order effects

  • Apple's later move to bring hypertension notifications to older Watch models suggests its health strategy can increasingly distribute validated capabilities through software, not solely through new hardware generations.
  • If accuracy validation remains the limiting factor, Apple Watch health differentiation will be paced by measurement reliability rather than by the annual hardware cycle.

The trend: Wearable-health roadmaps are shifting toward staged releases in which sensing hardware, validated interpretation, and software availability arrive on different timelines.

Discussion

  • @markgurman Mark Gurman on x
    New story: Apple aims to add blood pressure check to the Watch in 2024, but new sleep, women's health, medicine management, workout features coming this year. Also coming: Apple Watch low power mode, satellite SOS and more. https://www.bloomberg.com/...
  • @ivanthek @ivanthek on x
    I guess they didn't want to use the Siemens machines. 😉 https://twitter.com/...
  • @business @business on x
    BREAKING: Apple's plan to add a highly anticipated blood-pressure monitor to its watch has hit some snags and isn't expected to be ready until at least 2024 https://www.bloomberg.com/... https://twitter.com/...